Reports

As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.

Asia Pacific COVID-19 Diagnostics Market: By Test Type: PCR Test, Antigen Test, Antibody Test, Others; By Product; By Sample Type; By Business Model: Point-of-Care (PoC) Testing, Non-Point-of-Care (PoC) Testing; By End Use: Hospitals, Diagnostic Centres and Clinics, Laboratories; By Country (2020-2026); Competitive Landscape, 2021-2026

Asia Pacific COVID-19 Diagnostics Market Outlook

The Asia Pacific  COVID-19 diagnostics market is being aided by the growing cases of COVID-19 infections in India and China, which have performed around 234 million and 160 million tests, respectively, for COVID-19 as of March 2021.

 

Increasing Number of COVID-19 Cases is Driving the COVID-19 Diagnostics Industry Growth

The demand for COVID-19 diagnostics is growing due to a rise in the number of COVID positive cases, with China being initially the hardest affected country due to the country’s relatively higher population density. India emerged as the most adversely impacted country in the Asia Pacific owing to rapid cases of coronavirus in the country. Many Asia Pacific countries are scrambling to expand their scanning and research capabilities. Many large biotech and pharmaceutical firms have developed their own COVID-19 diagnostics, and many more are now saving, studying, and designing better and more sophisticated COVID-19 diagnostics. This, in particular, is supposed to generate attractive business growth prospects in the coming years. Government policies that benefit detection kit producers are enabling them to expand production volume, which is expected to boost the demand outlook.
 

COVID-19 Diagnostics: Industry Definition and Segmentation

COVID-19 diagnostics are standardized equipment used for the detection and diagnosis of Covid-19. These are manufactured by approved pharmaceutical manufacturers under strict government procedures.

By test type, the market is divided into:

  • PCR Test
  • Antigen Test
  • Antibody Test
  • Others

The market is categorised in terms of product into:

  • RT-PCR Assay Kits
  • Immunoassay Test Strips
  • Others

The market is divided on the basis of sample type into:

  • Nasopharyngeal Swab
  • Oropharyngeal (OP) Swab
  • Nasal Swab
  • Blood Test
  • Others

On the basis of business model, the industry is bifurcated into:

  • Point-of-Care (PoC) Testing 
  • Non-Point-of-Care (PoC) Testing

In terms of end use, the market is segmented into:

  • Hospitals
  • Diagnostic Centres and Clinics
  • Laboratories
  • Others

The EMR report looks into the regional markets of the product like China, India, Japan, ASEAN, Australia, among others. 

 

Increasing Demand for Nasopharyngeal Swabs Aiding the Growth of COVID-19 Diagnostics Market

The most revenue is expected to come from the nasopharyngeal swabs market. SARS-CoV-2 susceptibility, detection rate, and viral load have all been shown to be substantially higher in nasopharyngeal swabs than in other swab types. As a result, this swab type is most often used when checking for COVID-19 and determining SARS-CoV-2 load, resulting in the segment's highest revenue share. This segment is expected to rise at a lucrative pace during the forecast period, owing to increased demand and availability of nasopharyngeal swabs. Furthermore, nasopharyngeal swabs are used in the bulk of molecular diagnostic tests for infection diagnosis.
 

Key Industry Players in the Asia Pacific COVID-19 Diagnostics Market

The report gives a detailed analysis of the following key players in the Asia Pacific COVID-19 diagnostics market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:

  • Guangzhou Wondfo Biotech Co., Ltd.
  • SolGent Co., Ltd.
  • Biolidics Limited
  • PT Bio Farma (Persero)
  • Beijing Jinwofu Bioengineering Technology Co.,Ltd.
  • Mylab Discovery Solutions Pvt. Ltd.
  • Ellume Limited
  • Others

The comprehensive EMR report provides an in-depth assessment of the industry based on the Porter's five forces model along with giving a SWOT analysis.

*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.

1    Preface
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Snapshot
    6.1    Asia Pacific
7    Industry Opportunities and Challenges
8    Asia Pacific COVID-19 Overview

    8.1    Number of COVID-19 Cases in Asia Pacific
    8.2    Asia Pacific COVID-19 Cases by Country
    8.2.1    China
        8.2.2    Japan
        8.2.3    India
        8.2.4    ASEAN
        8.2.5    Australia
        8.2.6    Others
9    Asia Pacific COVID-19 Diagnostics Market Analysis
    9.1    Key Industry Highlights
    9.2    Asia Pacific COVID-19 Diagnostics Market (2020-2026)
    9.3    Asia Pacific COVID-19 Diagnostics Market by Test Type (2020-2026)
        9.3.1    PCR Test 
        9.3.2    Antigen Test
        9.3.3    Antibody Test
        9.3.4    Others 
    9.4    Asia Pacific COVID-19 Diagnostics Market by Product (2020-2026)
        9.4.1    RT-PCR Assay Kits
        9.4.2    Immunoassay Test Strips
        9.4.3    Others
    9.5    Asia Pacific COVID-19 Diagnostics Market by Sample Type (2020-2026)
        9.5.1    Nasopharyngeal Swab
        9.5.2    Oropharyngeal (OP) Swab
        9.5.3    Nasal Swab
        9.5.4    Blood Test
        9.5.5    Others
    9.6    Asia Pacific COVID-19 Diagnostics Market by Business Model (2020-2026)
        9.6.1    Point-of-Care (PoC) Testing
        9.6.2    Non-Point-of-Care (PoC) Testing
    9.7    Asia Pacific COVID-19 Diagnostics Market by End Use (2020-2026)
        9.7.1    Hospitals 
        9.7.2    Diagnostic Centres and Clinics
        9.7.3    Laboratories
        9.7.4    Others
    9.8    Asia Pacific COVID-19 Diagnostics Market by Region (2020-2026)
        9.8.1    China
        9.8.2    India
        9.8.3    Japan
        9.8.4    ASEAN
        9.8.5    Australia
        9.8.6    Others
10    Market Dynamics
    10.1    SWOT Analysis
        10.1.1    Strengths
        10.1.2    Weaknesses
        10.1.3    Opportunities
        10.1.4    Threats
    10.2    Porter’s Five Forces Analysis
        10.2.1    Supplier’s Power
        10.2.2    Buyer’s Power
        10.2.3    Threat of New Entrants
        10.2.4    Degree of Rivalry
        10.2.5    Threat of Substitutes
    10.3    EMR’s Key Indicators for Demand
    10.4    EMR’s Key Indicators for Price
11    Competitive Landscape
    11.1    Market Structure
    11.2    Company Profiles
        11.2.1    Guangzhou Wondfo Biotech Co., Ltd.
            11.2.1.1    Company Overview
            11.2.1.2    Product Portfolio
            11.2.1.3    Demographic Reach and Achievements
            11.2.1.4    Certifications
        11.2.2    SolGent Co., Ltd.
            11.2.2.1    Company Overview
            11.2.2.2    Product Portfolio
            11.2.2.3    Demographic Reach and Achievements
            11.2.2.4    Certifications
        11.2.3    Biolidics Limited
            11.2.3.1    Company Overview
            11.2.3.2    Product Portfolio
            11.2.3.3    Demographic Reach and Achievements
            11.2.3.4    Certifications
        11.2.4    PT Bio Farma (Persero)
            11.2.4.1    Company Overview
            11.2.4.2    Product Portfolio
            11.2.4.3    Demographic Reach and Achievements
            11.2.4.4    Certifications
        11.2.5    Beijing Jinwofu Bioengineering Technology Co.,Ltd.
            11.2.5.1    Company Overview
            11.2.5.2    Product Portfolio
            11.2.5.3    Demographic Reach and Achievements
            11.2.5.4    Certifications
        11.2.6    Mylab Discovery Solutions Pvt. Ltd. 
            11.2.6.1    Company Overview
            11.2.6.2    Product Portfolio
            11.2.6.3    Demographic Reach and Achievements
            11.2.6.4    Certifications
        11.2.7    Ellume Limited
            11.2.7.1    Company Overview
            11.2.7.2    Product Portfolio
            11.2.7.3    Demographic Reach and Achievements
            11.2.7.4    Certifications
        11.2.8    Others
12    Industry Events and Developments


List of Figures and Tables

1.    Asia Pacific COVID-19 Cases by Country
2.    Asia Pacific COVID-19 Diagnostics Market: Key Industry Highlights, 2020 and 2026
3.    Asia Pacific COVID-19 Diagnostics Market: Breakup by Test Type (USD Billion)
4.    Asia Pacific COVID-19 Diagnostics Market: Breakup by Product (USD Billion)
5.    Asia Pacific COVID-19 Diagnostics Market: Breakup by Sample Type (USD Billion)
6.    Asia Pacific COVID-19 Diagnostics Market: Breakup by Business Model (USD Billion)
7.    Asia Pacific COVID-19 Diagnostics Market: Breakup by End Use (USD Billion)
8.    Asia Pacific COVID-19 Diagnostics Market: Breakup by Country (USD Billion), 
9.    Asia Pacific COVID-19 Diagnostics Market Structure

Key Questions Answered in the Report

The Asia Pacific COVID-19 diagnostics market is being aided by the growing cases of COVID-19 infections in India and China, which have performed around 234 million and 160 million tests, respectively, for COVID-19 as of March 2021.

The major drivers of the industry such as rising research and development, rising cases of COVID-19, and favourable government policies, are aiding the market growth.

The key market trend guiding the growth of the industry includes the technological advancements.

The major regions in the industry are China, India, Japan, ASEAN, and Australia, among others.

The major test types available in the industry are PCR test, antigen test, and antibody test, among others.

The major products available in the industry are RT-PCR assay kits, and immunoassay test strips, among others.

The sample types available in the market are nasopharyngeal swab, oropharyngeal (OP) swab, nasal swab, and blood test, among others.

The significant business models are point-of-care (PoC) testing and non-point-of-care (PoC) testing.

The significant end use sectors are hospitals, diagnostic centres and clinics, and laboratories, among others.

The major players in the industry are Guangzhou Wondfo Biotech Co., Ltd., SolGent Co., Ltd., Biolidics Limited, PT Bio Farma (Persero), Beijing Jinwofu Bioengineering Technology Co.,Ltd., Mylab Discovery Solutions Pvt. Ltd., and Ellume Limited, among others.

Analyst Review

The Asia Pacific COVID-19 diagnostics market is being aided by the growing cases of COVID-19 infections in India and China, which have performed around 234 million and 160 million tests, respectively, for COVID-19 as of March 2021.The market is aided by favourable government policies and rise in funding for R&D in this field.

EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on its test types, the COVID-19 diagnostics industry can be segmented into PCR test, antigen test, and antibody test, among others. On the basis of products, the industry is divided into RT-PCR assay kits, and immunoassay test strips, among others. By sample types, the industry is categorised into nasopharyngeal swab, oropharyngeal (OP) swab, nasal swab, and blood test, among others. On the basis of business models, the industry is segmented into point-of-care (PoC) testing and non-point-of-care (PoC) testing. Based on end use sectors, the industry is segregated into hospitals, diagnostic centres and clinics, and laboratories, among others. The major regional markets for COVID-19 diagnostics in Asia Pacific are China, India, Japan, ASEAN, and Australia, among others. The key players in the above market include Guangzhou Wondfo Biotech Co., Ltd., SolGent Co., Ltd., Biolidics Limited, PT Bio Farma (Persero), Beijing Jinwofu Bioengineering Technology Co.,Ltd., Mylab Discovery Solutions Pvt. Ltd., and Ellume Limited, among others.

EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.

Purchase Full Report

Mini Report

$ 1999     $1499
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 3199     $2499
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

$ 4199     $3499
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 5199     $4499
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

RIGHT PEOPLE

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

RIGHT METHODOLOGY

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

RIGHT PRICE

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

RIGHT SUPPORT

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

Similar Reports

North America COVID-19 Diagnostics Market Report and Forecast 2021-2026


Global COVID-19 Diagnostics Market Report and Forecast 2021-2026


Europe COVID-19 Diagnostics Market Report and Forecast 2021-2026



Latin America COVID-19 Diagnostics Market Report and Forecast 2021-2026


NEWSLETTER